Sarepta Therapeutics, Inc. SRPT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s total equity?
- Sarepta Therapeutics, Inc. (SRPT) reported total equity of $1.51B in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s total equity changed year-over-year?
- Sarepta Therapeutics, Inc.'s total equity increased by 31.7% year-over-year, from $1.14B to $1.51B.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s total equity has grown at a 8.4% compound annual growth rate (CAGR), from $761.76M to $1.14B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.